Metabolic Messengers: ceramides | Nature Metabolism
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease | Nature Communications
Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancer | Nature Communications
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis | Science
IJMS | Free Full-Text | Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | HTML
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach - ScienceDirect
Role of ceramides in the pathogenesis of diabetes mellitus and its complications - ScienceDirect
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease | Nature Communications
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach - ScienceDirect
![PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/521ffada53075bca162dc03055312c91e84afbd6/9-Table1-1.png "PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar")
PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar
Mechanistic interplay between ceramide and insulin resistance | Scientific Reports
Palmitic and Oleic Acid: The Yin and Yang of Fatty Acids in Type 2 Diabetes Mellitus: Trends in Endocrinology & Metabolism
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis | Science
Ceramides – Lipotoxic Inducers of Metabolic Disorders: Trends in Endocrinology & Metabolism
Resilient hepatic mitochondrial function and lack of iNOS dependence in diet-induced insulin resistance - PLOS ONE - X-MOL
Mechanisms of muscle insulin resistance and the cross‐talk with liver and adipose tissue - Silva Rosa - 2020 - Physiological Reports - Wiley Online Library
Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels | Nature Communications
SMPDL3b modulates insulin receptor signaling in diabetic kidney disease | Nature Communications
PDF) Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis
The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach - ScienceDirect
![PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/521ffada53075bca162dc03055312c91e84afbd6/10-Table1-1.png "PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar")
PDF] Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells | Semantic Scholar
Role of ceramide synthase 2 in G-CSF signaling and G-CSF-R translocation into detergent-resistant membranes. - Sci. Rep. - X-MOL
Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling.,Nature Communications - X-MOL
A selective inhibitor of ceramide synthase 1 reveals a novel role in fat metabolism | Nature Communications
Publications | Holthuis Lab | Molecular Cell Biology Division | Universität Osnabrück
Cell-permeable ceramides increase basal glucose incorporation into triacylglycerols but decrease the stimulation by insulin in 3T3-L1 adipocytes | International Journal of Obesity
